Fibrosing cholestatic hepatitis after kidney transplantation from HCV-viremic donors to HCV-negative recipients: A unique complication in the DAA era.

Kapila, Nikhil; Al-Khalloufi, Kawtar; Bejarano, Pablo A; Vanatta, Jason M; Zervos, Xaralambos B

Kapila, Nikhil; Al-Khalloufi, Kawtar; Bejarano, Pablo A; Vanatta, Jason M; Zervos, Xaralambos B.

Afiliação

Kapila N; Department of Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, Florida.
Al-Khalloufi K; Division of Transplant Hepatology, Duke University, Durham, North Carolina.
Bejarano PA; Department of Transplant, Cleveland Clinic Florida, Weston, Florida.
Vanatta JM; Department of Pathology, Cleveland Clinic Florida, Weston, Florida.
Zervos XB; Department of Transplant, Cleveland Clinic Florida, Weston, Florida.

Am J Transplant ; 20(2): 600-605, 2020 02.

Article em En | MEDLINE | ID: mdl-31448549

Assuntos

Antivirais/uso terapêutico; Hepatite C/tratamento farmacológico; Viremia; Adulto; Idoso; Feminino; Hepatite C/etiologia; Humanos; Transplante de Rim/efeitos adversos; Masculino; Pessoa de Meia-Idade; Transplante de Órgãos; Doadores de Tecidos

Palavras-chave

antibiotic: antiviral; clinical research/practice; infection and infectious agents-viral: hepatitis C; infectious disease; liver disease: infectious; organ transplantation in general

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Viremia / Hepatite C Tipo de estudo: Etiology_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google